Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene signature and prognostic merit of M6a regulators in colorectal cancer.

Experimental biology and medicine (Maywood, N.J.) - 1 Sept 2020

Zhang Jinfeng, Cheng Xuedi, Wang Junzheng, Huang Yongjie, Yuan Junhui, Guo Dawen

Abstract excerpt

IMPACT STATEMENT: Although new diagnostic techniques and treatments are increasingly updated for CRC, the clinical outcomes of CRC patients are still not encouraging with a low survival rate. N6-methyladenosine (m6A) as a popular modification on mRNA is associated with multiple types of cancers. Our purpose is to identify gene signature and prognostic ability of m6A modulators in CRC. For the first time, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine
Share to Colorectal Neoplasms
Share to DNA Copy Number Variations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Neoplastic

Share to Mutation Rate

Share to Neoplasm Proteins

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 32605475
DOI: 10.1177/1535370220936145
PMCID: PMC7441353

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene signature and prognostic merit of M6a regulators in colorectal cancer.PMID 32605475Read ↗

Identification of an m6A-related lncRNA prognostic signature in colorectal cancer.Semantic proximity Read ↗

Gene Alterations of N6-Methyladenosine (m6A) Regulators in Colorectal Cancer: A TCGA Database Study.Semantic proximity Read ↗

Expression and Prognostic Characteristics of m6A RNA Methylation Regulators in Colon Cancer.Semantic proximity Read ↗

Evaluated the Role of N6-Methyladenosine-associated lncRNAs in Prognosis and Immune Microenvironment of Colorectal CancerSemantic proximity Read ↗

Bioinformatic analysis of N6-methyladenosine, 5-methylcytosine, and N1-methyladenosine co-regulation patterns and validation of NSUN6 as a protective protein in colon cancerSemantic proximity Read ↗

Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patientsSemantic proximity Read ↗

Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer.Semantic proximity Read ↗

Identification of N6-Methyladenosine-Related Gene Based Prognostic Signature to Predict Survival and Potential Therapeutic Drugs in GliomaSemantic proximity Read ↗

Effect of m1A regulators on prognosis of colorectal cancerSemantic proximity Read ↗

Exploring the role of m6A modification in cancerSemantic proximity Read ↗

Bioinformatics Construction and Experimental Validation of a novel N6- Methylandenosine(m6A)-related lncRNA signature predicts prognosis and immune microenvironment in colon cancerSemantic proximity Read ↗

Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.